ARCHIVES

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

This article is from The Cancer Letter archive.

Vol. 32 No. 27 | July 14, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Role, Issues In Education Considered By DRCCA Board

August 21, 1981

NCI Takes Action Against Investigators Who Gave Drug Without An IND; M.D. Anderson Contract Canceled

August 28, 1981

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

May 31, 2013

NCI Offers Informations, Resources, To Industry.

April 6, 2001

Cancer Training Programs Fairing Fairley Well

December 1, 1989

NIH Panel Outlines Strategies To Manage Adrenal Tumors.

February 22, 2002